Martin Hersberger Selected Research

Iron Overload

7/2010	Toll-like receptor 4 gene polymorphism modulates phenotypic expression in patients with hereditary hemochromatosis.
8/2006	Tumor necrosis factor-alpha -308G>A allelic variant modulates iron accumulation in patients with hereditary hemochromatosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martin Hersberger Research Topics

Disease

28	Inflammation (Inflammations) 01/2024 - 06/2004
11	Atherosclerosis 04/2014 - 06/2004
6	Coronary Artery Disease (Coronary Atherosclerosis) 01/2012 - 01/2005
5	Insulin Resistance 01/2021 - 09/2009
4	Myocardial Infarction 01/2014 - 03/2005
4	Infections 05/2009 - 08/2006
3	Major Depressive Disorder (Major Depressive Disorders) 01/2024 - 04/2021
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2023 - 08/2006
3	Cardiovascular Diseases (Cardiovascular Disease) 03/2023 - 06/2004
3	Heart Failure 01/2022 - 07/2007
3	Reperfusion Injury 01/2014 - 02/2013
3	Acute Coronary Syndrome 01/2014 - 04/2007
3	Disease Progression 03/2013 - 04/2004
3	Coronary Disease (Coronary Heart Disease) 03/2005 - 01/2003
2	Neoplasms (Cancer) 12/2023 - 01/2022
2	Epilepsy (Aura) 01/2020 - 01/2016
2	Ischemia 07/2018 - 01/2014
2	Inborn Errors Metabolism (Inborn Errors of Metabolism) 01/2016 - 01/2003
2	Atherosclerotic Plaque (Atheroma) 04/2014 - 07/2011
2	Unstable Angina 01/2014 - 07/2007
2	Heart Diseases (Heart Disease) 09/2011 - 01/2010
2	Hemochromatosis (Bronze Diabetes) 07/2010 - 08/2006
2	Iron Overload 07/2010 - 08/2006
2	Chronic Renal Insufficiency 05/2010 - 07/2007
2	Kidney Diseases (Kidney Disease) 05/2010 - 07/2007
2	Disorders of Excessive Somnolence (Hypersomnia) 01/2010 - 08/2006
2	Pulmonary Hypertension 01/2010 - 01/2010
2	Diabetes Mellitus 03/2007 - 06/2004
1	Colorectal Neoplasms (Colorectal Cancer) 12/2023
1	Hypotension (Low Blood Pressure) 05/2022
1	Hemolysis 02/2022
1	Atrophy 01/2022
1	Liver Diseases (Liver Disease) 01/2022

Drug/Important Bio-Agent (IBA)

18	LipidsIBA 12/2023 - 06/2004
8	Biomarkers (Surrogate Marker)IBA 03/2023 - 04/2007
6	EmulsionsIBA 12/2023 - 02/2015
5	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 06/2004
5	Insulin (Novolin)FDA Link 01/2021 - 06/2004
5	Proteins (Proteins, Gene)FDA Link 01/2016 - 03/2007
5	CholesterolIBA 10/2013 - 06/2004
5	CytokinesIBA 03/2013 - 06/2004
5	HDL CholesterolIBA 09/2009 - 01/2003
4	C-Reactive ProteinIBA 01/2024 - 06/2004
4	Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA 04/2014 - 08/2007
4	Apolipoproteins E (ApoE)IBA 03/2013 - 11/2004
3	IronIBA 01/2024 - 08/2006
3	phospholipid emulsion soybean oil (Intralipid)IBA 12/2023 - 02/2015
3	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 10/2023 - 01/2021
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 07/2007
3	EnzymesIBA 01/2019 - 08/2010
3	Neutralizing AntibodiesIBA 03/2013 - 09/2004
3	CreatinineIBA 05/2010 - 05/2007
2	fish oil triglyceridesIBA 12/2023 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 03/2005
2	resolvin D1IBA 11/2021 - 04/2016
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 04/2021 - 01/2021
2	IncretinsIBA 01/2021 - 01/2021
2	OxysterolsIBA 01/2019 - 06/2015
2	Messenger RNA (mRNA)IBA 01/2019 - 11/2012
2	Nitric Oxide Synthase (NO Synthase)IBA 01/2016 - 01/2010
2	Phosphotransferases (Kinase)IBA 12/2014 - 01/2014
2	LipoxygenasesIBA 04/2014 - 11/2012
2	FructoseIBA 03/2014 - 01/2014
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2014 - 03/2007
2	InflammasomesIBA 10/2013 - 07/2011
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 03/2013 - 10/2006
2	InterleukinsIBA 03/2013 - 07/2011
2	VaccinesIBA 03/2013 - 09/2004
2	Triglycerides (Triacylglycerol)IBA 02/2013 - 09/2009
2	Interleukin-4 (Interleukin 4)IBA 11/2012 - 11/2010
2	oxidized low density lipoproteinIBA 11/2012 - 09/2009
2	lipoxin A4IBA 02/2012 - 01/2012
2	ApolipoproteinsIBA 07/2011 - 10/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2010 - 08/2006
2	LipoxinsIBA 08/2010 - 01/2007
2	prostaglandin R2 D-isomerase (prostaglandin D2 synthase)IBA 05/2010 - 08/2006
2	OrexinsIBA 01/2010 - 09/2006
2	Serotonin (5 Hydroxytryptamine)IBA 01/2010 - 01/2010
2	Serum Amyloid A Protein (Serum Amyloid A)IBA 03/2005 - 06/2004
2	Protective AgentsIBA 03/2005 - 06/2004
2	HDL LipoproteinsIBA 06/2004 - 01/2003
1	Fatty Acid-Binding ProteinsIBA 01/2024
1	Ferritins (Ferritin)IBA 01/2024
1	Orosomucoid (Seromucoid)IBA 01/2024
1	Transferrin Receptors (Transferrin Receptor)IBA 01/2024
1	Dietary IronIBA 01/2024
1	alpha-Linolenic Acid (Linolenic Acid)IBA 03/2023
1	OxylipinsIBA 03/2023
1	Essential Fatty AcidsIBA 12/2022
1	Arginine Vasopressin (Argipressin)IBA 05/2022
1	Hemoglobins (Hemoglobin)IBA 02/2022
1	Collagen Type III (Type III Collagen)IBA 01/2022
1	Troponin T (Troponin T1)IBA 01/2022
1	Growth Differentiation Factor 15IBA 01/2022
1	Collagen Type I (Type I Collagen)IBA 01/2022
1	Galectin 3 (LGALS3)IBA 01/2022
1	collagen type I trimeric cross-linked peptideIBA 01/2022

Therapy/Procedure

4	Total Parenteral Nutrition 12/2022 - 01/2021
2	Therapeutics 12/2014 - 08/2006
1	Parenteral Nutrition 01/2022